Humira Biosimilar Market is Anticipated to Witness High Growth...

added blog Other

2024-02-26 12:03:19 -

The humira biosimilar market consists of biosimilar versions of the reference biologic drug Humira (adalimumab). Humira is indicated for the treatment of various autoimmune diseases such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis and others. The introduction of biosimilar versions of Humira provides a more cost effective treatment...

0 Comments 0 Shares 1K Views 0 Reviews